Simplex Trading’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-100
| Closed | -$451 | – | 9247 |
|
|
2025
Q4 | $451 | Sell |
100
-9,300
| -99% | -$47.6K | ﹤0.01% | 8174 |
|
|
2025
Q3 | $50K | Sell |
9,400
-1,000
| -10% | -$5.41K | ﹤0.01% | 6454 |
|
|
2025
Q2 | $56K | Sell |
10,400
-4,900
| -32% | -$19.4K | ﹤0.01% | 5807 |
|
|
2025
Q1 | $42K | Buy |
15,300
+10,200
| +200% | +$35.5K | ﹤0.01% | 5939 |
|
|
2024
Q4 | $17K | Sell |
5,100
-10,500
| -67% | -$30.3K | ﹤0.01% | 6800 |
|
|
2024
Q3 | $45K | Sell |
15,600
-3,200
| -17% | -$10.5K | ﹤0.01% | 5970 |
|
|
2024
Q2 | $63K | Buy |
18,800
+900
| +5% | +$2.94K | ﹤0.01% | 5834 |
|
|
2024
Q1 | $54K | Sell |
17,900
-600
| -3% | -$2.11K | ﹤0.01% | 6191 |
|
|
2023
Q4 | $77K | Buy |
18,500
+1,400
| +8% | +$7.59K | ﹤0.01% | 5634 |
|
|
2023
Q3 | $116K | Buy |
17,100
+11,300
| +195% | +$99.8K | ﹤0.01% | 4936 |
|
|
2023
Q2 | $60K | Sell |
5,800
-43,900
| -88% | -$393K | ﹤0.01% | 5636 |
|
|
2023
Q1 | $346K | Buy |
49,700
+20,400
| +70% | +$178K | ﹤0.01% | 3666 |
|
|
2022
Q4 | $176K | Buy |
29,300
+17,700
| +153% | +$131K | ﹤0.01% | 4375 |
|
|
2022
Q3 | $91K | Sell |
11,600
-13,800
| -54% | -$161K | ﹤0.01% | 5649 |
|
|
2022
Q2 | $345K | Buy |
25,400
+1,700
| +7% | +$28.1K | ﹤0.01% | 3916 |
|
|
2022
Q1 | $464K | Buy |
23,700
+200
| +0.9% | +$3.99K | ﹤0.01% | 3937 |
|
|
2021
Q4 | $806K | Sell |
23,500
-42,300
| -64% | -$1.7M | ﹤0.01% | 3158 |
|
|
2021
Q3 | $4.46M | Buy |
65,800
+6,600
| +11% | +$398K | ﹤0.01% | 1299 |
|
|
2021
Q2 | $4.35M | Buy |
59,200
+58,990
| +28,090% | +$5.9M | ﹤0.01% | 1310 |
|
|
2021
Q1 | $1.92M | Buy |
+210
| New | +$20.4K | ﹤0.01% | 1643 |
|
|
2020
Q4 | – | Sell |
-10
| Closed | -$46K | – | 8443 |
|
|
2020
Q3 | $46K | Buy |
+10
| New | +$558 | ﹤0.01% | 5674 |
|
Simplex Trading's CVAC Position: Q4 2025 in Review
Simplex Trading sold out of CureVac (CVAC) in Q4 2025, closing a stake of 14,903 shares — an estimated $76.3K sold.
Simplex Trading first reported a position in CVAC in Q4 2020 and held it in 15 quarters. The position peaked at $391K in Q1 2022. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.
- Simplex Trading reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 14,903 CureVac shares in Q4 2025, an estimated $76.3K.
- Simplex Trading first reported a position in CureVac in Q4 2020 and held it in 15 quarters.
- Simplex Trading's CureVac position peaked at $391K in Q1 2022.
- 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.